Summary
Although hemorrhage remains one of the two major complications in the field of obstetrics, new approaches to its control are continuously being developed and explored. This chapter summarizes the current management approach for the in-house obstetrician and anesthesiologist who are the first line of the management team.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 2000;182:760–766.
Sachs BP, Brown DA, Driscoll SG, et al. Maternal mortality in Massachusetts. Trends and prevention. N Engl J Med 1987;316:667–672.
Drife J. Management of primary postpartum haemorrhage. Br J Obstet Gynaecol 1997;104:275–277.
Panchal S, Arria AM, Harris AP. Intensive care utilization during hospital admission for delivery: prevalence, risk factors, and outcomes in a statewide population. Anesthesiology 2000;92:1537–1544.
Panchal S, Arria AM, Labhsetwar SA. Maternal mortality during hospital admission for delivery: a retrospective analysis using a state-maintained database. Anesth Analg 2001;93:134–141.
Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967;98:394–403.
Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol 1979;86:364–370.
Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol 1976;126:671–677.
Duthie SJ, Ven D, Yung GL, et al. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991;38:119–124.
Duthie SJ, Ghosh A, Ng A, Ho PC. Intra-operative blood loss during elective lower segment caesarean section. Br J Obstet Gynaecol 1992;99:364–367.
Robson SC, Boys RJ, Hunter S, Dunlop W. Maternal hemodynamics after normal delivery and delivery complicated by postpartum hemorrhage. Obstet Gynecol 1989;74:234–239.
Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69–76.
Thaler I, Manor D, Itskovitz J, et al. Changes in uterine blood flow during human pregnancy. Am J Obstet Gynecol 1990;162:121–125.
Nelson SH, Suresh MS. Lack of reactivity of uterine arteries from patients with obstetric hemorrhage. Am J Obstet Gynecol 1992;166:1436–1443.
Huszar GB, Walsh MP. Relationship between myometrial and cervical functions in pregnancy and labor. Semin Perinatol 1991;15:97–117.
Combs CA, Laros RK Jr. Prolonged third stage of labor: morbidity and risk factors. Obstet Gynecol 1991;77:863–867.
Dombrowski MP, Bottoms SF, Saleh AA, et al. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol 1995; 172:1279–1284.
Elbourne DR, Prendiville WJ, Carroli G, et al. Prophylactic use of oxytocin in the third stage of labour (Cochrane Review). Cochrane Database Syst Rev 2001;4:CD001808.
Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev 2000;CD000007.
Roberts WE. Emergent obstetric management of postpartum hemorrhage. Obstet Gynecol Clin N Am 1995;22:283–302.
Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993;48:15–18.
Gilstrap LC III, Ramin SM. Postpartum hemorrhage. Clin Obstet Gynecol 1994;37:824–830.
Alamia V Jr, Meyer BA. Peripartum hemorrhage. Obstet Gynecol Clin N Am 1999;26:385–398.
Ledee N, Ville Y, Musset D, et al. Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol 2001;94:189–196.
Zelop CM, Harlow BL, Frigoletto FD Jr, et al. Emergency peripartum hysterectomy. Am J Obstet Gynecol 1993;168:1443–1448.
Chestnut DH, Eden RD, Gall SA, Parker RT. Peripartum hysterectomy: a review of cesarean and postpartum hysterectomy. Obstet Gynecol 1985;65:365–370.
Pelage JP, Soyer P, Repiquet D, et al. Secondary postpartum hemorrhage: treatment with selective arterial embolization. Radiology 1999; 212:385–389.
Heffner LJ, Mennuti MT, Rudoff JC, McLean GK. Primary management of postpartum vulvovaginal hematomas by angiographic embolization. Am J Perinatol 1985;2:204–207.
Weis FR Jr, Markello R, Mo B, Bochiechio P. Cardiovascular effects of oxytocin. Obstet Gynecol 1975;46:211–214.
Bider D, Dulitzky M, Goldenberg M, et al. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta. Eur J Obstet Gynecol Reprod Biol 1996;64:59–61.
Hayashi RH, Castillo MS, Noah ML. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue. Obstet Gynecol 1984;63:806–808.
O’Brien P, El Refaey H, Gordon A, et al. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998;92: 212–214.
Gerstenfeld TS, Wing DA. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. Am J Obstet Gynecol 2001;185:878–882.
Amant F, Spitz B, Timmerman D, et al. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial. Br J Obstet Gynaecol 1999;106:1066–1070.
Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990;162:205–208.
Brown BJ, Heaston DK, Poulson AM, et al. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization. Obstet Gynecol 1979;54:361–365.
Vedantham S, Goodwin SC, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 1997;176:938–948.
AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994;171:694–700.
Deux JF, Bazot M, Le Blanche AF, et al. Is selective embolization of uterine arteries a safe alternative to hysterectomy in patients with postpartum hemorrhage? AJR Am J Roentgenol 2001;177:145–149.
Yamashita Y, Takahashi M, Ito M, Okamura H. Transcatheter arterial embolization in the management of postpartum hemorrhage due to genital tract injury. Obstet Gynecol 1991;77:160–163.
Villella J, Garry D, Levine G, et al. Postpartum angiographic embolization for vulvovaginal hematoma. A report of two cases. J Reprod Med 2001;46:65–67.
Greenwood LH, Glickman MG, Schwartz PE, et al. Obstetric and nonmalignant gynecologic bleeding: treatment with angiographic embolization. Radiology 1987;164:155–159.
Rosenthal DM, Colapinto R. Angiographic arterial embolization in the management of postoperative vaginal hemorrhage. Am J Obstet Gynecol 1985;151:227–231.
Sieber PR. Bladder necrosis secondary to pelvic artery embolization: case report and literature review. J Urol 1994;151:422.
Burchell RC. Physiology of internal iliac artery ligation. J Obstet Gynaecol Br Commonw 1968;75:642–651.
Clark SL, Phelan JP, Yeh SY, Bruce SR, Paul RH. Hypogastric artery ligation for obstetric hemorrhage. Obstet Gynecol 1985;66:353–356.
Chattopadhyay SK, Deb RB, Edrees YB. Surgical control of obstetric hemorrhage: hypogastric artery ligation or hysterectomy? Int J Gynaecol Obstet 1990;32:345–351.
O’Leary JA. Uterine artery ligation in the control of postcesarean hemorrhage. J Reprod Med 1995;40:189–193.
Fahmy K. Uterine artery ligation to control postpartum hemorrhage. Int J Gynaecol Obstet 1987;25:363–367.
Chestnut DH, Dewan DM, Redick LF, et al. Anesthetic management for obstetric hysterectomy: a multi-institutional study. Anesthesiology 1989;70:607–610.
Castaneda S, Karrison T, Cibils LA. Peripartum hysterectomy. J Perinat Med 2000;28:472–481.
Clark SL, Yeh SY, Phelan JP, et al. Emergency hysterectomy for obstetric hemorrhage. Obstet Gynecol 1984;64:376–380.
Kamani AA, McMorland GH, Wadsworth LD. Utilization of red blood cell transfusion in an obstetric setting. Am J Obstet Gynecol 1988;159: 1177–1181.
Ripley DL. Uterine emergencies. Atony, inversion, and rupture. Obstet Gynecol Clin N Am 1999;26:419–434, vii.
Sarna MC, Soni AK, Gomez M, Oriol NE. Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg 1997;84: 753–756.
Herman A, Weinraub Z, Bukovsky I, et al. Dynamic ultrasonographic imaging of the third stage of labor: new perspectives into third-stage mechanisms. Am J Obstet Gynecol 1993;168:1496–1499.
Fox H. Placenta accreta, 1945–1969. Obstet Gynecol Surv 1972;27:475.
Zaki ZM, Bahar AM, Ali ME, et al. Risk factors and morbidity in patietns with placenta previa accreta compared to placenta previa nonaccreta. Acta Obstet Gynecol Scand 1998;77:391–394.
Levine D, Hulka CA, Ludmir J, et al. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997;205:773–776.
Hall MH, Halliwell R, Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol 1985;92:732–738.
Romero R, Hsu YC, Athanassiadis AP, et al. Preterm delivery: a risk factor for retained placenta. Am J Obstet Gynecol 1990;163:823–825.
Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988;95:3–16.
Nordstrom L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol 1997;104:781–786.
Khan GQ, John IS, Wani S, et al. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol 1997;177:770–774.
Rogers J, Wood J, McCandlish R, et al. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet 1998;351:693–699.
Sorbe B. Active pharmacologic management of the third stage of labor. A comparison of oxytocin and ergometrine. Obstet Gynecol 1978;52: 694–697.
McDonald S, Prendiville WJ, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta. Cochrane Database Syst Rev 2000;CD000201.
Soriano D, Dulitzki M, Schiff E, et al. A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol 1996;103:1068–1073.
Gulmezoglu AM. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2000;CD000494.
Sellers SM, Hodgson HT, Mitchell MD, et al. Raised prostaglandin levels in the third stage of labor. Am J Obstet Gynecol 1982;144:209–212.
Walley RL, Wilson JB, Crane JM, et al. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. Br J Obstet Gynaecol 2000;107:1111–1115.
Hofmeyr GJ, Nikodem VC, de Jager M, Gelbart BR. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998;105:971–975.
Gulmezoglu AM, Villar J, Ngoc NT, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689–695.
Ridgway LE. Puerperal emergency. Vaginal and vulvar hematomas. Obstet Gynecol Clin N Am 1995;22:275–282.
Shah-Hosseini R, Evrard JR. Puerperal uterine inversion. Obstet Gynecol 1989;73:567–570.
Wendel PJ, Cox SM. Emergent obstetric management of uterine inversion. Obstet Gynecol Clin N Am 1995;22:261–274.
Brar HS, Greenspoon JS, Platt LD, Paul RH. Acute puerperal uterine inversion. New approaches to management. J Reprod Med 1989;34: 173–177.
Watson P, Besch N, Bowes WA Jr. Management of acute and subacute puerperal inversion of the uterus. Obstet Gynecol 1980;55:12–16.
Catanzarite VA, Moffitt KD, Baker ML, et al. New approaches to the management of acute puerperal uterine inversion. Obstet Gynecol 1986;68:7S–10S.
Kovacs BW, Devore GR. Management of acute and subacute puerperal uterine inversion with terbutaline sulfate. Am J Obstet Gynecol 1984; 150:784–786.
Dayan SS, Schwalbe SS. The use of small-dose intravenous nitroglycerin in a case of uterine inversion. Anesth Analg 1996;82:1091–1093.
Thiery M, Delbeke L. Acute puerperal uterine inversion: two-step management with a beta-mimetic and a prostaglandin. Am J Obstet Gynecol 1985;153:891–892.
Hawkins JL, Koonin LM, Palmer SK, Gibbs CP. Anesthesia-related deaths during obstetric delivery in the United States, 1979–1990. Anesthesiology 1997;86:277–284.
DeSimone CA, Norris MC, Leighton BL. Intravenous nitroglycerin aids manual extraction of a retained placenta. Anesthesiology 1990;73:787.
Rocke DA, Rout CC, Murray WB. Predicting difficulty of laryngoscopy. Anaesth Intensive Care 1993;21:260–261.
Rocke DA, Murray WB, Rout CC, Gouws E. Relative risk analysis of factors associated with difficult intubation in obstetric anesthesia. Anesthesiology 1992;77:67–73.
Jouppila R, Jouppila P, Hollmen A. Laryngeal oedema as an obstetric anaesthesia complication: case reports. Acta Anaesthesiol Scand 1980; 24:97–98.
Pilkington S, Carli F, Dakin MJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth 1995;74:638–642.
Naef RW III, Morrison JC. Transfusion therapy in pregnancy. Clin Obstet Gynecol 1995;38:547–557.
Babineau TJ, Dzik WH, Borlase BC, et al. Reevaluation of current transfusion practices in patients in surgical intensive care units. Am J Surg 1992;164:22–25.
Cousins LM, Teplick FB, Poeltler DM. Pre-cesarean blood bank orders: a safe and less expensive approach. Obstet Gynecol 1996;87:912–916.
Ransom SB, Fundaro G, Dombrowski MP. The cost-effectiveness of routine type and screen admission testing for expected vaginal delivery. Obstet Gynecol 1998;92:493–495.
Camann WR, Datta S. Red cell use during cesarean delivery. Transfusion 1991;31:12–15.
Klapholz H. Blood transfusion in contemporary obstetric practice. Obstet Gynecol 1990;75:940–943.
Mallett SV, Peachey TD, Sanehi O, et al. Reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia 2000;55:1013–1019.
BCSH Blood Transfusion and Haematology Task Forces. The estimation of fetomaternal haemorrhage. Transfus Med 1999;9:87–92.
Consensus Conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700–2703.
Naef RW III, Washburne JF, Martin RW, et al. Hemorrhage associated with cesarean delivery: when is transfusion needed? J Perinatol 1995; 15:32–35.
Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998;279:199–205.
Thurer RL. Evaluating transfusion triggers. JAMA 1998;279:238–239.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685–1690.
Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:229–235.
Ekeroma AJ, Ansari A, Stirrat GM. Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol 1997;104:278–284.
Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583–590.
Kruskall MS, Leonard S, Klapholz H. Autologous blood donation during pregnancy: analysis of safety and blood use. Obstet Gynecol 1987; 70:938–941.
Andres RL, Piacquadio KM, Resnik R. A reappraisal of the need for autologous blood donation in the obstetric patient. Am J Obstet Gynecol 1990;163:1551–1553.
McVay PA, Hoag RW, Hoag MS, Toy PT. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol 1989;160:1479–1486.
O’Dwyer G, Mylotte M, Sweeney M, Egan EL. Experience of autologous blood transfusion in an obstetrics and gynaecology department. Br J Obstet Gynaecol 1993;100:571–574.
Combs CA, Murphy EL, Laros RK Jr. Cost-benefit analysis of autologous blood donation in obstetrics. Obstet Gynecol 1992;80:621–625.
Grange CS, Douglas MJ, Adams TJ, Wadsworth LD. The use of acute hemodilution in parturients undergoing cesarean section. Am J Obstet Gynecol 1998;178:156–160.
Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth 1998;80:195–198.
Rebarber A, Lonser R, Jackson S, et al. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 1998;179:715–720.
Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991;98:909–918.
Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol 1998;105:314–321.
Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001;97:1915–1919.
Letsky EA. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 2001;15:623–644.
Gilstrap LC III, Hauth JC, Hankins GD, Patterson AR. Effect of type of anesthesia on blood loss at cesarean section. Obstet Gynecol 1987; 69:328–332.
Munson ES, Embro WJ. Enflurane, isoflurane, and halothane and isolated human uterine muscle. Anesthesiology 1977;46:11–14.
Marx GF, Kim YI, Lin CC, Halevy S, Schulman H. Postpartum uterine pressures under halothane or enflurance anesthesia. Obstet Gynecol 1978;51:695–698.
Lynch CB, Adeyemi C, et al. Br J Obstet Gynaecol 1997;104:372–375.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Sarna, M.C., Hess, P., Takoudes, T.C., Chaudhury, A.K. (2004). Postpartum Hemorrhage. In: Datta, S., Hepner, D.L. (eds) Anesthetic and Obstetric Management of High-Risk Pregnancy. Springer, New York, NY. https://doi.org/10.1007/0-387-21572-7_9
Download citation
DOI: https://doi.org/10.1007/0-387-21572-7_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-00443-3
Online ISBN: 978-0-387-21572-3
eBook Packages: Springer Book Archive